Monitor efficacy of Itolizumab, not just safety, in Covid trials -- expert panel tells Biocon
Naeem Mulla Sunday 6th of December 2020 03:32 PM
(0) (0)
Govt's expert panel, that advises the apex drug regulator, has asked Biocon to submit a revised proposal for phase 4 trials of Itolizumab, which already has emergency use approval.
Read more: THEPRINT.IN
Leave Your Response